what are the pros and cons of tirzepatide Day 3: Mounjaro (Tirzepatide – weekly injection) Class: Dual GLP-1 GIP receptor agonist Avg Weight Loss: ~20% baseline weight (SURMOUNT-1 trial) FDA Status: Approved for type 2 diabetes; Fast-tracked for What Is Zepbound (tirzepatide)? Uses,
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28




:max_bytes(150000):strip_icc():focal(749x0:751x2)/Rachel-McRady-Mom-on-GLP-1-Tout-031726-6e65bdd3fb154ca2b321a950a48e213e.jpg)




:max_bytes(150000):strip_icc():focal(748x241:750x243)/Serena-Williams-1-012726-2698f17c5ab647929a79194c436d85ea.jpg)











